Vulcan Value Partners reported 36 stock positions worth $3.3B in its 2026 Q2 Form 13F, for the quarter ended Jun 30, 2026, filed Aug 10, 2026. Its largest position is EVEREST GROUP, LTD. (EG), at 11.28% of the reported portfolio value. Its biggest move versus the previous quarter was in UNITEDHEALTH GROUP INC (UNH), where it cut the position by 92.6%.
| Ticker | Company | Weight | Shares | Change |
|---|---|---|---|---|
| EG | EVEREST GROUP, LTD. | 11.28% | 1,036,906 | TRIMMED (-23.9%) |
| MSFT | MICROSOFT CORP | 11.21% | 986,905 | TRIMMED (-11.0%) |
| RYAN | RYAN SPECIALTY HOLDINGS, INC. | 9.09% | 7,912,669 | ADDED (+20.0%) |
| MA | Mastercard Inc | 7.86% | 502,961 | ADDED (+31.3%) |
| AMZN | AMAZON COM INC | 7.20% | 992,758 | TRIMMED (-37.8%) |
| TDG | TransDigm Group INC | 6.91% | 170,429 | TRIMMED (-7.5%) |
| ARES | Ares Management Corp | 6.45% | 1,902,580 | ADDED (+12.5%) |
| TRU | TransUnion | 5.94% | 2,707,249 | TRIMMED (-15.6%) |
| GOOG | Alphabet Inc. | 5.80% | 539,472 | TRIMMED (-20.3%) |
| V | VISA INC. | 4.84% | 463,268 | TRIMMED (-27.6%) |
| TPG | TPG Inc. | 2.92% | 2,361,862 | ADDED (+18.9%) |
| MEDP | Medpace Holdings, Inc. | 2.28% | 141,743 | TRIMMED (-30.2%) |
| ELV | Elevance Health, Inc. | 1.83% | 155,873 | TRIMMED (-47.5%) |
| NOW | ServiceNow, Inc. | 1.74% | 574,811 | ADDED (+7.7%) |
| IQV | IQVIA HOLDINGS INC. | 1.53% | 259,856 | ADDED (+4.7%) |
| KMX | CARMAX INC | 1.47% | 912,638 | TRIMMED (-58.6%) |
| FISV | FISERV INC | 1.33% | 893,965 | TRIMMED (-18.3%) |
| NICE | NICE Ltd. | 1.32% | 478,421 | TRIMMED (-16.4%) |
| HEI.A | HEICO CORP | 1.21% | 153,718 | TRIMMED (-13.9%) |
| JLL | JONES LANG LASALLE INC | 0.91% | 96,258 | TRIMMED (-12.1%) |
| UNH | UNITEDHEALTH GROUP INC | 0.85% | 67,309 | TRIMMED (-92.6%) |
| CRM | Salesforce, Inc. | 0.78% | 164,013 | TRIMMED (-16.7%) |
| CIGI | Colliers International Group Inc. | 0.60% | 211,910 | TRIMMED (-17.0%) |
| ABM | ABM INDUSTRIES INC /DE/ | 0.60% | 448,559 | TRIMMED (-28.8%) |
| MLKN | MILLERKNOLL, INC. | 0.52% | 838,151 | TRIMMED (-36.7%) |
| QRVO | Qorvo, Inc. | 0.51% | 181,315 | TRIMMED (-32.5%) |
| EFX | EQUIFAX INC | 0.44% | 90,748 | NEW |
| G | Genpact LTD | 0.44% | 521,587 | TRIMMED (-26.6%) |
| SARO | StandardAero, Inc. | 0.41% | 450,287 | TRIMMED (-37.2%) |
| PRG | PROG Holdings, Inc. | 0.40% | 281,066 | TRIMMED (-50.4%) |
| FBIN | Fortune Brands Innovations, Inc. | 0.36% | 214,798 | TRIMMED (-37.5%) |
| BMI | BADGER METER INC | 0.31% | 68,684 | NEW |
| LFUS | LITTELFUSE INC /DE | 0.24% | 17,448 | TRIMMED (-77.7%) |
| ITRN | Ituran Location & Control Ltd. | 0.23% | 124,028 | TRIMMED (-74.9%) |
| VEEV | VEEVA SYSTEMS INC | 0.11% | 21,240 | NEW |
| IWD | ISHARES RUSSELL 1000 VALUE E | 0.05% | 7,011 | NEW |
Exited this quarter: PK.
Source: SEC Form 13F filing for the quarter ended Jun 30, 2026, filed Aug 10, 2026. CIK 0001556785. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only and report holdings as of quarter-end; each filing is due within 45 days after quarter-end, so the filing lag above is the gap between quarter-end and this filing’s date, and it varies by when the manager actually filed.
Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.
Hypothetical 13F-clone performance — not the fund’s actual returns. The clone holds the long U.S. equity positions disclosed in this manager’s Form 13F filings at their reported weights, rebalanced on filing dates, on dividend-adjusted prices. Full series and the filing-by-filing evidence dossier: 13F-clone profile.
A snapshot at quarter-end, not today’s portfolio: 13F filings arrive up to 45 days late, cover long positions only, and omit cash, shorts, and derivatives. Copying this list also means copying its timing, prices, and position sizes.
Read the original filings at SEC EDGAR.
Not investment advice. Filings are delayed and incomplete.
How we measure: Methodology · Track Record · Q3 2026 13F tracker.
See the same rule applied to every tracked fund, including this one: Follow a Fund — each quarter’s top 5 new and increased positions, bought at the close on the first trading day after the 13F deadline and held for a quarter, scored against SPY.
Compare overlap → Compare your own book against this fund and the other tracked funds.
Oakmark Funds · Track Record: how the signals scored · Compare overlap
One email a week: the week’s new filings and research. Subscribe free
← Viking Global Investors · W.H. Reaves & Co. →
Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.